申请人:Fatheree Paul R.
公开号:US20140135333A1
公开(公告)日:2014-05-15
In one aspect, the invention relates to compounds having the formula:
wherein: Ar, Z, R
3
, R
4
and R
5
are as defined in the specification, or a pharmaceutically acceptable salt thereof. These compounds have AT
1
receptor antagonist activity and neprilysin inhibition activity. In another aspect, the invention relates to pharmaceutical compositions comprising such compounds; methods of using such compounds; and process and intermediates for preparing such compounds.
在一个方面,本发明涉及具有以下式子的化合物:其中:Ar,Z,R3,R4和R5如规范中所定义,或其药学上可接受的盐。这些化合物具有AT1受体拮抗活性和神经肽酶抑制活性。在另一个方面,本发明涉及包含这些化合物的制药组合物;使用这些化合物的方法;以及制备这些化合物的过程和中间体。